药品检测市场规模、份额和成长分析（按产品、样品、药物、最终用途和地区）- 产业预测 2025-2032

全球药品检测市场预计将在 2023 年达到 59 亿美元，并从 2024 年的 62.1 亿美元成长到 2032 年的 93.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.2%。

由于政府机构对解决酒精和药物测试安全问题的监管要求不断提高，药物测试市场预计将经历显着增长。持续的监测和预防药物成瘾的努力进一步加剧了这一趋势。此外，全球药物滥用现象增加，加上新冠疫情对精神健康的影响，以及企业倒闭和景气衰退，都增加了对全面筛检解决方案的需求。这包括检测非法药物和处方药物，以及运动员使用的增强体质的物质。随着人们对此类问题的认识不断提高，预计各种生物样本的药物检测服务需求将激增，为市场扩张提供充足的机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

药品检测市场规模（依产品及复合年增长率） (2025-2032)

• 市场概况
• 耗材
• 装置
• 快速检测装置
• 服务

药品检测市场规模（按样本和复合年增长率） (2025-2032)

• 市场概况
• 尿液样本
• 口腔液体样本
• 头髮样本
• 其他范例

药品检测市场规模（依药品类别及复合年增长率） (2025-2032)

• 市场概况
• 酒精
• 大麻
• 古柯碱
• 阿片类药物
• 安非他命和甲基安非他命
• LSD（兴奋剂）
• 其他的

药品检测市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 药品检测实验室
• 职场
• 医院
• 其他的

药品检测市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Laboratory Corporation of America Holdings（LabCorp）（USA）
• Abbott Laboratories（USA）
• Thermo Fisher Scientific Inc.（USA）
• Siemens Healthineers AG（Germany）
• F. Hoffmann-La Roche Ltd（Switzerland）
• OraSure Technologies, Inc.（USA）
• Alfa Scientific Designs, Inc.（USA）
• Dragerwerk AG & Co. KGaA（Germany）
• Randox Testing Services（UK）
• United States Drug Testing Laboratories, Inc.（USDTL）（USA）
• Psychemedics Corporation（USA）
• Cordant Health Solutions（USA）
• Omega Laboratories, Inc.（USA）
• Clinical Reference Laboratory, Inc.（USA）
• Premier Biotech, Inc.（USA）
• Danaher Corporation（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Shimadzu Corporation（Japan）
• Lifeloc Technologies, Inc.（USA）

结论和建议

Global Drug Testing Market size was valued at USD 5.9 billion in 2023 and is poised to grow from USD 6.21 billion in 2024 to USD 9.31 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The drug testing market is poised for significant growth, driven by increasing regulatory demands from government agencies for alcohol and drug testing to address safety concerns. The ongoing efforts to monitor and prevent substance addiction further underscore this trend. Additionally, the global rise in substance misuse, exacerbated by the mental health impact of the COVID-19 pandemic-along with business closures and economic downturns-has heightened the need for comprehensive screening solutions. This includes the detection of both illicit and prescribed medications, as well as performance-enhancing substances used by athletes. As awareness of these issues grows, the demand for drug testing services across various biological samples is expected to surge, presenting ample opportunities for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Testing Market Segmental Analysis

Global Drug Testing Market is segmented by Product, Sample, Drug, End Use and region. Based on Product, the market is segmented into Consumables, Instruments, Rapid Testing Devices and Services. Based on Sample, the market is segmented into Urine Samples, Oral Fluid Samples, Hair Samples and Other Samples. Based on Drug, the market is segmented into Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD and Others. Based on End Use, the market is segmented into Drug Testing Laboratories, Workplaces, Hospitals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Testing Market

The primary driver propelling the growth of the Global Drug Testing market is the rising rates of drug and alcohol consumption globally. Reports indicate a significant increase in substance abuse, with approximately 275 million individuals aged 15-64 using drugs at least once in 2019, according to the World Drug Report 2021. This troubling trend led to around 36.3 million people grappling with drug dependence, causing substantial health and societal issues, including nearly 500,000 fatalities and the loss of 18 million years of healthy life linked primarily to opioid use. The escalating prevalence of drug and alcohol abuse, notably concerning impaired driving incidents, underscores the urgent need for effective drug testing solutions, thereby driving demand for drug screening products and services, which is expected to significantly enhance overall market growth.

Restraints in the Global Drug Testing Market

The growth of the Global Drug Testing market is expected to be hindered by prohibitions on workplace drug testing in several countries. Nations such as Canada, Colombia, Argentina, Chile, and South Africa view these testing practices as violations of employee privacy. In France, for instance, pre-employment drug testing is only permitted under a physician's prescription. Meanwhile, countries like Poland and the Czech Republic have deemed workplace drug and alcohol testing illegal. Additionally, specific regulations in Eastern Canada allow for such testing solely in high-risk occupational scenarios or select situations. These restrictions in various regions could significantly constrain the overall development and acceptance of drug and alcohol testing in their respective markets.

Market Trends of the Global Drug Testing Market

The Global Drug Testing market is witnessing a significant shift towards innovative, non-invasive solutions, particularly driven by the emergence of fingerprint-based drug testing. Accelerated by the COVID-19 pandemic, this technology offers a hygienic, portable, and rapid alternative to traditional methods, addressing safety concerns associated with viral transmission in clinical settings. As organizations increasingly adopt fingerprint analysis for its ease of use and minimal sample collection requirements, the method demonstrates potential for wider application in workplaces, law enforcement, and rehabilitation programs. This evolving landscape presents substantial growth opportunities for industry players, positioning fingerprint-based tests as a future replacement for conventional urine, hair, and blood tests.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Drug Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Consumables
• Instruments
• Rapid Testing Devices
• Services

Global Drug Testing Market Size by Sample & CAGR (2025-2032)

• Market Overview
• Urine Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

Global Drug Testing Market Size by Drug & CAGR (2025-2032)

• Market Overview
• Alcohol
• Cannabis/Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Others

Global Drug Testing Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Drug Testing Laboratories
• Workplaces
• Hospitals
• Others

Global Drug Testing Market Size & CAGR (2025-2032)

• North America (Product, Sample, Drug, End Use)
  • US
  • Canada
• Europe (Product, Sample, Drug, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Sample, Drug, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Sample, Drug, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Sample, Drug, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Laboratory Corporation of America Holdings (LabCorp) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alfa Scientific Designs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dragerwerk AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Testing Services (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• United States Drug Testing Laboratories, Inc. (USDTL) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psychemedics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordant Health Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omega Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinical Reference Laboratory, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Biotech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifeloc Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations